Aziyo Biologics Inc - Class A
AZYO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$65.89M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $65.89 Million |
|---|---|
| Enterprise Value | $50.38 Million |
| Earnings per Share | $1.29 |
| Beta | -0.08 |
| Outstanding Shares | 44,223,722 |
Return
| Return on Equity | 329.02% |
|---|---|
| Return on Assets | 118.69% |
| Return on Invested Capital | -116.67% |
Valuation & Multiples
| P/E Ratio | 0.64 |
|---|---|
| PEG | -3.15 |
| Price to Sales | -1.49 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -47.84 |
| Enterprise Value to EBIT | -1.91 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
Institutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 36.78%▼ 2.50% |
|---|---|
| Total Invested | $16.00M▲ 43.49% |
| Investors Holding | 34▲ 1.00% |
About Aziyo Biologics Inc
163 employees
Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable...